Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma

Yan Wu, Young Suk Kwon, Mina Labib, David Foran, Eric Singer

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


As the most common neoplasm arising from the kidney, renal cell carcinoma (RCC) continues to have a significant impact on global health. Conventional cross-sectional imaging has always served an important role in the staging of RCC. However, with recent advances in imaging techniques and postprocessing analysis, magnetic resonance imaging (MRI) now has the capability to function as a diagnostic, therapeutic, and prognostic biomarker for RCC. For this narrative literature review, a PubMed search was conducted to collect the most relevant and impactful studies from our perspectives as urologic oncologists, radiologists, and computational imaging specialists. We seek to cover advanced MR imaging and image analysis techniques that may improve the management of patients with small renal mass or metastatic renal cell carcinoma.

Original languageEnglish (US)
Article number648495
JournalDisease Markers
StatePublished - 2015

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma'. Together they form a unique fingerprint.

Cite this